ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1297

A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus

Tala El Tal1, Abdulaziz el Mutairi1, Amanda Steiman2 and Earl Silverman3, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2Sinai Health System, Toronto, ON, Canada, 3The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Access to care, Quality Indicators, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multi-system autoimmune disease affecting 1 in 1000 individuals, of whom 20% develop the disease in childhood. Childhood-onset SLE (cSLE) is typically more severe than adult-onset disease, with increased morbidity and mortality further amplified by risk of attrition on transfer from paediatric to adult care. Two key indicators for successful transition have been proposed: i) patient not being lost to follow up after transfer, and ii) attended all scheduled visits in adult care for at a least a year after transfer.Studies have shown only 50% of paediatric rheumatology patients transition successfully to adult care. Recognizing this risk, we established a paediatric-adult provider dyad transition care model for youth with cSLE in Aug 2016. This begins with a transition clinic at The Hospital for Sick Children (Sickkids) for those turning 18, wherein patients first meet their adult care team, and then transition to Young Adult SLE (YASLE) clinic at Mount Sinai Hospital (MSH). This is a combined clinic staffed by both paediatric and adult rheumatologists that manage all patients collaboratively until the age of 22 years, at which point patients are transferred to adult rheumatology clinic, staffed by the same adult rheumatologist. The purpose of this study was to evaluate the success of this unique transition model from paediatric to adult care.

Methods: A comprehensive retrospective chart review of all cSLE (meeting 1997 ACR or 2012 SLICC Classification Criteria for SLE) graduates from Sickkids at 18 years was conducted since model initiation (Aug 2016) until Dec 2021. Based on the above indicators for “successful transition”, the following outcome measures were reviewed: number of cSLE patients who 1) graduated from Sickkids at 18 years during this time period, 2) attended transition clinic 3) planned to go to MSH vs. other clinic, 4) presented to MSH after transfer (first attrition metric) 5) continued to be followed at least a year after transfer (second attrition metric) and 6) graduated from YASLE clinic to adult rheumatology clinic. Descriptive statistics was used.

Results: A total of 232 cSLE patients graduated from Sickkids over this timeframe. Of those, 58% (n=134) cSLE patients were slated for MSH (42% (n=98) for other clinics). Of 134 cSLE patients, two (1%) did not attend their SickKids transition clinic appointments yet later presented to MSH. One hundred thirty-two (99%) presented to MSH for their first visit, while 1% (n=2) were lost to follow up. Of these 132 cSLE patients, 91% (n=120) were seen within 1 year of transfer, and 99% (n=131) continued to be seen at least a year after transfer vs. one patient (1%) was lost to follow up. Of 66 YASLE clinic patients aged ≥ 22 years, 41% (n=27) graduated and transferred to adult rheumatology clinic, while the majority of the rest (n = 27, 75%) were booked for sometime in the future, or still attending a final YASLE clinic; a small number had moved away (n = 4, 11%).

Conclusion: This unique transition care model rooted in a paediatric-adult provider partnership promotes timely and seamless transfer and transition, which ultimately optimizes healthcare transition outcomes.


Disclosures: T. El Tal, None; A. el Mutairi, None; A. Steiman, Pfizer, Jannsen; E. Silverman, None.

To cite this abstract in AMA style:

El Tal T, el Mutairi A, Steiman A, Silverman E. A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/a-paediatric-adult-provider-dyad-care-model-improves-transition-from-paediatric-to-adult-health-care-for-youth-with-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-paediatric-adult-provider-dyad-care-model-improves-transition-from-paediatric-to-adult-health-care-for-youth-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology